Merck is advancing a subcutaneous Keytruda formulation, which, if approved before LOE, generates a new formulation patent layer, a new dosage form that physicians and patients may prefer over IV infusion, and potentially a new period of data exclusivity under the NDA supplement
These are the most common type of seizure and follow pattern, beginning with the tonic phase and transitioning into the clonic phase
L-Carnitine is a naturally occurring amino acid that has the overall effect of burning fat, boost energy and reduce fatigue
It was developed in the early 1990s by the Danish pharmaceutical company Novo Nordisk, who were looking for a long-acting yet therapeutically effective treatment of type 2 diabetes [1]
Schurks M, Glynn RJ, Rist PM, Tzourio C, Kurth T
These findings are intriguing but do not yet constitute definitive clinical guidance